Ventriculitis and nosocomial meningitis caused by carbapenem-resistant Gram-negative and vancomycin-resistant Gram-positive bacteria represent a growing treatment challenge. A case of ventriculitis and bacteremia caused by carbapenem-resistant, KPC-producing Klebsiella pneumoniae and vancomycin-resistant Enterococcus faecium in a young woman with acute leukemia who was successfully treated with meropenem/vaborbactam (MVB), rifampicin, and linezolid is described in this paper. This case report emphasizes the importance of a multidisciplinary strategy, including infectious focus control, for the treatment of device-associated central nervous system (CNS) infections from multidrug-resistant bacteria. Considering the novel resistance patterns, more research on drug penetration into the central nervous system, as well as on the necessity of association therapies, is needed.
Rubino, R., Trizzino, M., Pipitò, L., Sucato, G., Santoro, M., Maugeri, R., et al. (2024). A Difficult Case of Ventriculitis in a 40-Year-Old Woman with Acute Myeloid Leukemia. ANTIBIOTICS, 13(5), 1-9 [10.3390/antibiotics13050432].
A Difficult Case of Ventriculitis in a 40-Year-Old Woman with Acute Myeloid Leukemia
Rubino, Raffaella
Primo
;Trizzino, MarcelloSecondo
;Santoro, Marco;Maugeri, Rosario;Iacopino, Domenico Gerardo;Giammanco, Giovanni Maurizio;Siragusa, SergioPenultimo
;Cascio, AntonioUltimo
2024-05-10
Abstract
Ventriculitis and nosocomial meningitis caused by carbapenem-resistant Gram-negative and vancomycin-resistant Gram-positive bacteria represent a growing treatment challenge. A case of ventriculitis and bacteremia caused by carbapenem-resistant, KPC-producing Klebsiella pneumoniae and vancomycin-resistant Enterococcus faecium in a young woman with acute leukemia who was successfully treated with meropenem/vaborbactam (MVB), rifampicin, and linezolid is described in this paper. This case report emphasizes the importance of a multidisciplinary strategy, including infectious focus control, for the treatment of device-associated central nervous system (CNS) infections from multidrug-resistant bacteria. Considering the novel resistance patterns, more research on drug penetration into the central nervous system, as well as on the necessity of association therapies, is needed.File | Dimensione | Formato | |
---|---|---|---|
antibiotics-13-00432.pdf
accesso aperto
Descrizione: Articolo
Tipologia:
Versione Editoriale
Dimensione
2.77 MB
Formato
Adobe PDF
|
2.77 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.